Renal Neoplasms with Concurrent Castleman-Like Regional Lymphadenopathy
Alcino Gama,Ruoji Zhou,Ivan De La Riva-Morales,Jeffrey Sosman,Bogdan Isaila,Qing C Chen,Xiaoqi Lin,Bonnie Choy,Yi-Hua Chen,Ximing J. Yang
DOI: https://doi.org/10.1177/10668969241271421
2024-09-03
International Journal of Surgical Pathology
Abstract:International Journal of Surgical Pathology, Ahead of Print. IntroductionRenal cell neoplasms are known to be associated with paraneoplastic syndromes, and the association with Castleman-like regional lymphadenopathy has been rarely reported. We aim to characterize the association between renal neoplasms and Castleman-like lymphadenopathy.MethodsA search for renal neoplasms with concurrent Castleman-like lymphadenopathy in one single medical institution from 2000 to 2023 resulted in 4 specimens. A literature search for "Castleman" and "renal neoplasm" resulted in 8 reports. Patients' demographics, clinical presentation, gross and histologic features, results of ancillary studies, treatment, and follow-up were evaluated.ResultsOur patients included 3 men and 1 woman, with a mean age of 60 years. Four different subtypes of renal neoplasms were diagnosed, including clear cell renal cell carcinoma (RCC), papillary RCC, chromophobe RCC, and mucinous cystadenoma of the renal pelvis. For Castleman-like regional lymphadenopathy, 2 were plasma-cell predominant, and 2 were hyaline-vascular. After a median follow-up of 84 months, all patients were alive with no recurrence or progression of Castleman-like features following nephrectomies.ConclusionCastleman-like regional lymphadenopathy should be considered in patients with renal tumors and lymphadenopathy. Although more prevalent in clear cell RCC, it can be also associated with other renal neoplasms. The concurrent lymphadenopathy was remitted following the renal tumor resections.
pathology,surgery